ArticleInternational journal of cosmetic science2025
Anti-melanogenic effects of Medicago sativa seed extracts on melanocytes.
Article in International journal of cosmetic science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anti-melanogenic effects of Medicago sativa seed extracts on melanocytes.International journal of cosmetic science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAlfalfa (Medicago sativa) is a prominent herbal treatment among Asian countries and its antioxidant and anti-inflammatory effects have already been generally elucidated. Excessive melanin synthesis is one of the major troubles in the cosmetics industry, thus such research has been extensively described. Here, we investigated the anti-melanogenic effects and molecular mechanisms of two types of alfalfa extracts: alfalfa ethanol precipitate (AEP) and alfalfa ethanol supernatant (AES).
methodsThe chemical composition of AEP and AES was analysed using HPAEC-PAD and LC-MS/MS. B16F10 cells and MNT-1 cells were used to demonstrate the inhibitory effect of two alfalfa seed extracts on melanin synthesis. The gene expression and protein levels of tyrosinase, tyrosinase-related protein 1 (TRP1), DCT and microphthalmia-associated factor (MITF) were confirmed using semi-quantitative RT-PCR, western blot and immunocytochemistry. Furthermore, the underlying mechanisms of these factors were elucidated in B16F10. The inhibitory effect on melanogenesis was validated using 3D artificial skin (MelanoDerm).
resultsBoth AEP and AES reduced melanin content in B16F10 cells stimulated with α-melanocyte-stimulating hormone (α-MSH) and subsequently decreased mRNA and protein levels of the melanogenesis-related targets, tyrosinase, TRP1 and MITF, as shown by semi-quantitative RT-PCR and immunocytochemistry. In addition, AEP and AES reduced protein levels of the MITF upstream regulators such as extracellular signal-mitogen-activated protein kinases (ERK), cAMP response element-binding protein (CREB) and β-catenin. Similar inhibition of melanin production and decreased expression of tyrosinase protein and MITF mRNA and protein were also confirmed in MNT-1 human melanoma cells. Using artificial human skin tissue (MelanoDerm), a significant reduction in melanin content was observed.
conclusionAlfalfa seed extracts exert an inhibitory effect on the melanin production process by modulating the activity of ERK, CREB and β-catenin, thereby suppressing MITF and reducing the levels of tyrosinase, TRP1 and DCT. Collectively, these findings suggest that alfalfa extracts may be a promising avenue for further research and development in the fields of cosmetics and pharmaceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.